Administration of DM-αKG evidently suppressed tumor growth in a DR6- and GSDMC-dependent manner (Fig. 5a, b) and was associated with DM-αKG-induced GSDMC cleavage (Fig. 5c). The gene discussed is DMPK; the disease is neoplasm.